Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicines for Malaria Venture

https://www.mmv.org/

Latest From Medicines for Malaria Venture

QuantumDX Inks Deal To Distribute IVD Tests In China

The CEO of QuantumDX, Jonathan O’Halloran, spoke to Medtech Insight about the benefits of selling diagnostics in China and argued for a pragmatic approach to IP protection when launching in a country where counterfeiting is common.

In Vitro Diagnostics Deals

New Front-Runner Emerges In China mRNA Booster Race

China's CSPC Pharmaceutical Group surprises by announcing investigator-initiated trial results for SYS6006, its mRNA COVID-19 vaccine candidate against the Omicron variant.

China Clinical Trials

China Clears HIV Oral Antiviral For COVID, Vows More Drug Approvals

As the Communist Party of China gears up for its once in every five years National Congress late this fall, the need for more novel drugs to help address the persistent coronavirus pandemic is rising amid the country’s strict “COVID Zero” policies.

China Approvals

BeiGene Latest Chinese Biotech To Double Down On mRNA For Cancer

Chinese biotechs have reached deals for cancer therapies to explore the novel uses of messenger RNA technology beyond COVID-19 vaccines, as the mRNA COVID-19 vaccine fame starts fading.

Commercial China
See All

Company Information

  • Industry
  • Academic and Research Institutions
UsernamePublicRestriction

Register